Yahoo Finance

Postmenopausal Osteoporosis Pipeline Research Report 2023: Comprehensive Insights About 20+ Companies and 20+ Pipeline Drugs

Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Postmenopausal osteoporosis - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides ...
Business Wire

Reportlinker Adds Pipeline and Commercial Insight: Osteoporosis - Novel Agents to Battle for Payer Acceptance

NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Pipeline and Commercial ...
Yahoo Finance

Radius Pharmaceuticals Announces Licensing Agreement with Pharmanovia to Register and Commercialize Abaloparatide in China and Select Asia Pacific Territories

BOSTON, MA / ACCESSWIRE / January 2, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on ...
Medindia

Commercial Insight: Osteoporosis - Market Players Maximize Revenue Growth Before the Next Challenging Phase Report now Available on ReportsandReports

DALLAS, Texas, June 7, 2010 ReportsandReports Announce itWill Carry the Commercial Insight Osteoporosis Market Players MaximizeRevenue Growth Before the Next ...
Business Wire

2022 Postmenopausal Osteoporosis Pipeline Insight Report: Featuring PhytoHealth, Luye Pharma, Sandoz International and Addpharma Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Postmenopausal Osteoporosis - Pipeline Insight, 2022" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights ...
Science Daily

Commercial ties may be fueling unnecessary, potentially harmful osteoporosis treatment

A complex web of interactions between industry, advocacy organizations, and academia may be fueling enthusiasm for calcium and vitamin D supplements to prevent and treat osteoporosis, despite evidence ...